Sat.Jan 21, 2023

article thumbnail

Tech forgot its umbrella

TechCrunch

Welcome to Startups Weekly, a nuanced take on this week’s startup news and trends by Senior Reporter and Equity co-host Natasha Mascarenhas. To get this in your inbox, subscribe here. It kind of feels like tech forgot its umbrella.

article thumbnail

Termination Shock (Book Review)

Continuations

Over vacation I read Termination Shock by Neal Stephenson. Unlike many other recent books tackling the climate crisis , it is entirely focused on the controversial issue of geoengineering through solar radiation modification (SMR). The basic idea of SMR is to let slightly less sunlight into the Earth’s lower atmosphere where it can heat things up. Even a tiny decrease in solar radiation will have a big impact on global warming.

support 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alphabet makes cuts, Twitter bans third-party clients, and Netflix’s Reed Hastings steps down

TechCrunch

Howdy, folks! Happy Friday. While our fearless Week in Review leader Greg enjoys parental leave, I’m filling in, curating the latest on the tech news front. It was a roller coaster of a week once again as economic headwinds took a brutal, demoralizing toll, and as chaos reigned at Elon Musk’s Twitter. Somewhere in the midst of all that, Boston Dynamics demoed an improved bipedal robot, Wikipedia launched a redesign and major universities banned TikTok from their campus networks.

article thumbnail

Protect me from what I want

TechCrunch

W elcome to the TechCrunch Exchange, a weekly startups-and-markets newsletter. It’s inspired by the daily TechCrunch+ column where it gets its name. Want it in your inbox every Saturday? Sign up here. Buy now, pay later is an alluring option for consumers, perhaps even more so in a recession.

article thumbnail

Rethinking Growth: The Fight to Become and Stay Profitable

Speaker: Aleksey Krylov, CFA - Chief Financial Officer at CytoImmune Therapeutics

Join Aleksey Krylov, corporate finance expert and CFO at CytoImmune Therapeutics, for an insightful overview of working capital management and managing profitability.